Interestingly, similar to NFATC2, STAT1, and c-Fos, Bcl-2 was significantly upregulated (p<0.05) in the low CTLA4-expressing CLL group (Figure 4C). This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.